S Dawood1, S D Merajver2, P Viens3, P B Vermeulen4, S M Swain5, T A Buchholz6, L Y Dirix7, P H Levine8, A Lucci9, S Krishnamurthy10, F M Robertson11, W A Woodward6, W T Yang12, N T Ueno13, M Cristofanilli14. 1. Department of Medical Oncology, Dubai Hospital, Department of Health and Medical Services, Dubai, United Arab Emirates. 2. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. 3. Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. 4. Department of Pathology, General Hospital Sint-Augustinus, Antwerp, Belgium. 5. Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA. 6. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 7. Translational Cancer Research Group Antwerp, General Hospital Sint-Augustinus, Antwerp, Belgium. 8. Department of Epidemiology and Biostatistics, School of Public Health and Health Services, George Washington University, Washington, DC. 9. Department of Surgical Oncology. 10. Department of Pathology. 11. Department of Experimental Therapeutics. 12. Department of Diagnostic Radiology. 13. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. 14. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: Massimo.Cristofanilli@fccc.edu.
Abstract
BACKGROUND: Inflammatory breast cancer (IBC) represents the most aggressive presentation of breast cancer. Women diagnosed with IBC typically have a poorer prognosis compared with those diagnosed with non-IBC tumors. Recommendations and guidelines published to date on the diagnosis, management, and follow-up of women with breast cancer have focused primarily on non-IBC tumors. Establishing a minimum standard for clinical diagnosis and treatment of IBC is needed. METHODS: Recognizing IBC to be a distinct entity, a group of international experts met in December 2008 at the First International Conference on Inflammatory Breast Cancer to develop guidelines for the management of IBC. RESULTS: The panel of leading IBC experts formed a consensus on the minimum requirements to accurately diagnose IBC, supported by pathological confirmation. In addition, the panel emphasized a multimodality approach of systemic chemotherapy, surgery, and radiation therapy. CONCLUSIONS: The goal of these guidelines, based on an expert consensus after careful review of published data, is to help the clinical diagnosis of this rare disease and to standardize management of IBC among treating physicians in both the academic and community settings.
BACKGROUND: Inflammatory breast cancer (IBC) represents the most aggressive presentation of breast cancer. Women diagnosed with IBC typically have a poorer prognosis compared with those diagnosed with non-IBC tumors. Recommendations and guidelines published to date on the diagnosis, management, and follow-up of women with breast cancer have focused primarily on non-IBC tumors. Establishing a minimum standard for clinical diagnosis and treatment of IBC is needed. METHODS: Recognizing IBC to be a distinct entity, a group of international experts met in December 2008 at the First International Conference on Inflammatory Breast Cancer to develop guidelines for the management of IBC. RESULTS: The panel of leading IBC experts formed a consensus on the minimum requirements to accurately diagnose IBC, supported by pathological confirmation. In addition, the panel emphasized a multimodality approach of systemic chemotherapy, surgery, and radiation therapy. CONCLUSIONS: The goal of these guidelines, based on an expert consensus after careful review of published data, is to help the clinical diagnosis of this rare disease and to standardize management of IBC among treating physicians in both the academic and community settings.
Authors: Sabin B Motwani; Eric A Strom; Naomi R Schechter; Charles E Butler; Gordon K Lee; Howard N Langstein; Steven J Kronowitz; Funda Meric-Bernstam; Nuhad K Ibrahim; Thomas A Buchholz Journal: Int J Radiat Oncol Biol Phys Date: 2006-06-09 Impact factor: 7.038
Authors: Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine Journal: J Natl Cancer Inst Date: 2005-07-06 Impact factor: 13.506
Authors: N Cabioglu; Y Gong; R Islam; K R Broglio; N Sneige; A Sahin; A M Gonzalez-Angulo; P Morandi; C Bucana; G N Hortobagyi; M Cristofanilli Journal: Ann Oncol Date: 2007-03-09 Impact factor: 32.976
Authors: Ana M Gonzalez-Angulo; Nour Sneige; Aman U Buzdar; Vicente Valero; Shu-Wan Kau; Kristine Broglio; Yuko Yamamura; Gabriel N Hortobagyi; Massimo Cristofanilli Journal: Clin Cancer Res Date: 2004-09-15 Impact factor: 12.531
Authors: F Conti; S Carpano; D Sergi; L Di Lauro; A Amodio; P Vici; M I Abbate; F R Ferranti; G Viola; C Botti; P Foggi; I Sperduti; M Lopez Journal: Clin Ter Date: 2007 Jul-Aug
Authors: Massimo Cristofanilli; Ana Maria Gonzalez-Angulo; Aman U Buzdar; Shu-Wan Kau; Debbie K Frye; Gabriel N Hortobagyi Journal: Clin Breast Cancer Date: 2004-02 Impact factor: 3.225
Authors: Selin Carkaci; Homer A Macapinlac; Massimo Cristofanilli; Osama Mawlawi; Eric Rohren; Ana M Gonzalez Angulo; Shaheenah Dawood; Erika Resetkova; Huong T Le-Petross; Wei-Tse Yang Journal: J Nucl Med Date: 2009-01-21 Impact factor: 10.057
Authors: Adam R Wolfe; Rachel L Atkinson; Jay P Reddy; Bisrat G Debeb; Richard Larson; Li Li; Hiroko Masuda; Takae Brewer; Bradley J Atkinson; Abeena Brewster; Naoto T Ueno; Wendy A Woodward Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-01 Impact factor: 7.038
Authors: Hideko Yamauchi; Wendy A Woodward; Vicente Valero; Ricardo H Alvarez; Anthony Lucci; Thomas A Buchholz; Takayuki Iwamoto; Savitri Krishnamurthy; Wei Yang; James M Reuben; Gabriel N Hortobágyi; Naoto T Ueno Journal: Oncologist Date: 2012-05-14
Authors: H Arias-Pulido; A Cimino-Mathews; N Chaher; C Qualls; N Joste; C Colpaert; J D Marotti; M Foisey; E R Prossnitz; L A Emens; S Fiering Journal: Breast Cancer Res Treat Date: 2018-06-01 Impact factor: 4.872
Authors: Julie S Wecsler; Welela Tereffe; Rose C Pedersen; Michelle R Sieffert; Wendy J Mack; Haiyan Cui; Christy A Russell; Ryan R Woods; Rebecca K Viscusi; Stephen F Sener; Julie E Lang Journal: Breast Cancer Res Treat Date: 2015-04-07 Impact factor: 4.872
Authors: Sharareh Siamakpour-Reihani; Kouros Owzar; Chen Jiang; Peter M Scarbrough; Oana I Craciunescu; Janet K Horton; Holly K Dressman; Kimberly L Blackwell; Mark W Dewhirst Journal: Int J Hyperthermia Date: 2015-03-26 Impact factor: 3.914
Authors: María Gabriela Vallone; Virginia Mariana González; José Gabriel Casas; Margarita Larralde Journal: An Bras Dermatol Date: 2018-03 Impact factor: 1.896